LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 25.79 | 27.76 | 226 | 1605 | 0.1408 | 0.4308 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 25.79 | 27.76 | 1944 | 1605 | 1.2111 | 1.0665 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 27.49 | 27.76 | 121 | 1723 | 0.0702 | 0.2804 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 27.49 | 27.76 | 2137 | 1723 | 1.2402 | 1.0736 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 27.49 | 27.76 | 263 | 1723 | 0.1526 | 0.4587 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 27.49 | 27.76 | 2087 | 1723 | 1.2112 | 1.0654 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 29.19 | 27.76 | 134 | 1863 | 0.0719 | 0.2962 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 29.19 | 27.76 | 2321 | 1863 | 1.2457 | 1.0737 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 29.19 | 27.76 | 313 | 1863 | 0.1680 | 0.4906 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 29.19 | 27.76 | 2243 | 1863 | 1.2039 | 1.0621 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 30.90 | 27.76 | 160 | 2032 | 0.0787 | 0.3268 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 30.90 | 27.76 | 2512 | 2032 | 1.2360 | 1.0696 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 30.90 | 27.76 | 387 | 2032 | 0.1904 | 0.5302 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 30.90 | 27.76 | 2402 | 2032 | 1.1819 | 1.0547 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 32.60 | 27.76 | 239 | 2235 | 0.1069 | 0.4050 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 32.60 | 27.76 | 2774 | 2235 | 1.2407 | 1.0693 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 32.60 | 27.76 | 431 | 2235 | 0.1928 | 0.5421 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 32.60 | 27.76 | 2578 | 2235 | 1.1530 | 1.0455 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 34.30 | 27.76 | 268 | 2449 | 0.1094 | 0.4202 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 34.30 | 27.76 | 3000 | 2449 | 1.2246 | 1.0637 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 34.30 | 27.76 | 505 | 2449 | 0.2061 | 0.5665 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 34.30 | 27.76 | 2887 | 2449 | 1.1785 | 1.0515 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 36.01 | 27.76 | 307 | 2662 | 0.1153 | 0.4406 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 36.01 | 27.76 | 3232 | 2662 | 1.2137 | 1.0597 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 36.01 | 27.76 | 547 | 2662 | 0.2054 | 0.5726 | MN20160318_Q01 | M15 |